4.7 Article

Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension

期刊

HYPERTENSION
卷 74, 期 4, 页码 776-783

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/HYPERTENSIONAHA.119.13512

关键词

blood pressure monitoring; ambulatory; hypertension; United States

资金

  1. European Union [HEALTH-F7-305507 HOMAGE, LSHM-CT-2006-037093, HEALTH-F4-2007-201550]
  2. European Research Council [2011-294713-EPLORE, 713601-uPROPHET]
  3. European Research Area Net for Cardiovascular Diseases [JTC2017-046-PROACT]
  4. Research Foundation Flanders, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13]
  5. Ministry of Culture, Sports, Science, and Technology, Tokyo, Japan [16H05243, 16K09472, 16K11850, 16K15359, 17H04126, 17H06533, 17K15853, 17K19930, 18K09674, 18K09904, 18K17396]
  6. Japan Arteriosclerosis Prevention Fund
  7. Ministry of Health, Labor, and Welfare, Tokyo, Japan [H26Junkankitou [Seisaku]-Ippan-001, H29-Junkankitou-Ippan-003]
  8. Ministry of Agriculture, Forestry and Fisheries, Japan [NouEi 2-02]
  9. Asociacion Espanola Primera en Salud
  10. Danish Heart Foundation [01-2-9-9A-22914]
  11. Lundbeck Fonden [R32-A2740]
  12. National Natural Science Foundation of China [81470533, 91639203, 81770455]
  13. Ministry of Science and Technology, Beijing, China [2015AA020105-06, 2016YFC1300100, 2018YFC1704902]
  14. Shanghai Commissions of Science and Technology [14ZR1436200, 15XD1503200]
  15. Shanghai Bureau of Health [15GWZK0802, 2017BR025]
  16. National Institute of Aging [5 R01 AG036469-05, 1R03AG054186]
  17. Fondo Nacional de Ciencia, Tecnologia e Innovacion [G-97000726]
  18. Foundation for Polish Science
  19. National Institutes of Health
  20. Shanghai Bureau of Health (Grant for Leading Academics)
  21. Showa Pharmaceutical University [H28-4]
  22. Grants-in-Aid for Scientific Research [17H06533] Funding Source: KAKEN

向作者/读者索取更多资源

The new American College of Cardiology/American Heart Association guideline reclassified office blood pressure and proposed thresholds for ambulatory blood pressure (ABP). We derived outcome-driven ABP thresholds corresponding with the new office blood pressure categories. We performed 24-hour ABP monitoring in 11 152 participants (48.9% women; mean age, 53.0 years) representative of 13 populations. We determined ABP thresholds resulting in multivariable-adjusted 10-year risks similar to those associated with elevated office blood pressure (120/80 mm Hg) and stages 1 and 2 of office hypertension (130/80 and 140/90 mm Hg). Over 13.9 years (median), 2728 (rate per 1000 person-years, 17.9) people died, 1033 (6.8) from cardiovascular disease; furthermore, 1988 (13.8), 893 (6.0), and 795 (5.4) cardiovascular and coronary events and strokes occurred. Using a composite cardiovascular end point, systolic/diastolic outcome-driven thresholds indicating elevated 24-hour, daytime, and nighttime ABP were 117.9/75.2, 121.4/79.6, and 105.3/66.2 mm Hg. For stages 1 and 2 ambulatory hypertension, thresholds were 123.3/75.2 and 128.7/80.7 mm Hg for 24-hour ABP, 128.5/79.6 and 135.6/87.1 mm Hg for daytime ABP, and 111.7/66.2 and 118.1/72.5 mm Hg for nighttime ABP. ABP thresholds derived from other end points were similar. After rounding, approximate thresholds for elevated 24-hour, daytime, and nighttime ABP were 120/75, 120/80, and 105/65 mm Hg, and for stages 1 and 2, ambulatory hypertension 125/75 and 130/80 mm Hg, 130/80 and 135/85 mm Hg, and 110/65 and 120/70 mm Hg. Outcome-driven ABP thresholds corresponding to elevated blood pressure and stages 1 and 2 of hypertension are similar to those proposed by the current American College of Cardiology/American Heart Association guideline.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据